Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_assertion type Assertion NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_head.
- NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_assertion description "[The high prevalence of the V617F mutation of Janus kinase 2 and associated mutations in myeloproliferative disorders (> 95% in polycythemia vera and about half of patients with essential thrombocythemia and primary myelofibrosis) has led the World Health Organization to alter the diagnostic criteria for these myeloproliferative disorders, and these changes are reviewed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_provenance.
- NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_assertion evidence source_evidence_literature NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_provenance.
- NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_assertion SIO_000772 18300758 NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_provenance.
- NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_assertion wasDerivedFrom befree-2016 NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_provenance.
- NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_assertion wasGeneratedBy ECO_0000203 NP657424.RA_ui4dgSgq1NqheeTx6z5ixa_kEJWrK67rSakP7znasM130_provenance.